Dynamics of clinical symptoms in patients with pandemic influenza A (H1N1)

Clinical Microbiology and Infection

Volumn 16, Issue 4, 2010, Pages 389-390

  Lee, C S ^a   Lee, J H ^a  

^a Chonbuk National University Medical School   (South Korea)

Author keywords

Dynamic; Influenza; Pandemic; Symptom

Indexed keywords

OSELTAMIVIR;

ARTICLE; CHILD; CLINICAL FEATURE; COUGHING; DIARRHEA; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; DYSPNEA; FEMALE; HEADACHE; HIGH RISK POPULATION; HUMAN; INFLUENZA A (H1N1); INFLUENZA VIRUS A H1N1; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MALE; MYALGIA; NAUSEA; NONHUMAN; NOSE CONGESTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RHINORRHEA; SCHOOL CHILD; SORE THROAT; SYMPTOM; UPPER RESPIRATORY TRACT INFECTION; VIRUS PNEUMONIA; VOMITING;

INFLUENZA A VIRUS;

EID: 77950928852     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2010.03117.x     Document Type: Article

References (6)

1. Dawood FS, Jain S, Finelli L. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009, 360:2605-2615.
2. Swine-origin influenza A (H1N1) virus infections in a school - New York City, April 2009. MMWR Morb Mortal Wkly Rep 2009, 58:470-472.
3. Carrat F, Vergu E, Ferguson NM. Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Am J Epidemiol 2008, 167:775-785.
4. Predy GN, Goel V, Lovlin R, Donner A, Stitt L, Basu TK. Efficacy of an extract of North American ginseng containing poly-furanosyl-pyranosyl-saccharides for preventing upper respiratory tract infections: a randomized controlled trial. CMAJ 2005, 173:1043-1048.
5. Neumann G, Noda T, Kawaoka Y. Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature 2009, 459:931-939.
6. Pandemic (H1N1). 2009, http://www.who.int/csr/disease/swineflu/en/index.html, Geneva, World Health Organization, Available at: (last accessed 19 October 2009